Kimberly Nicholson, MD
Dermatology · Woodstock, GANPI 1427210475
Payments from drug & device makers
Across 340 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sanofi$769
- LEO Pharma Inc.$542
- Merz North America, Inc.$469
- Regeneron Healthcare Solutions, Inc.$431
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$424
- plus $3K from 29 others
What the payments were for
- Food & beverage$6,920100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $1,217 |
| Sanofi | 27 | $769 |
| LEO Pharma Inc. | 28 | $542 |
| Merz North America, Inc. | 1 | $469 |
| Regeneron Healthcare Solutions, Inc. | 18 | $431 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 23 | $424 |
| Novartis | 16 | $335 |
| Galderma Laboratories, L.p. | 21 | $303 |
| Mayne Pharma Commercial LLC | 16 | $277 |
| Incyte Corporation | 15 | $269 |
| UCB, Inc. | 11 | $239 |
| Sun Pharmaceutical Industries Inc. | 11 | $203 |
| Dermavant Sciences, Inc. | 8 | $194 |
| Johnson & Johnson | 9 | $162 |
| Botanix SB Inc | 7 | $139 |
| Pfizer | 7 | $121 |
| Amgen | 6 | $121 |
| Lilly USA, LLC | 6 | $121 |
| VYNE Pharmaceuticals Inc. | 6 | $89 |
| Organon | 5 | $77 |
| Arcutis Biotherapeutics, Inc. | 4 | $72 |
| Almirall LLC | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Medtronic | 2 | $33 |
| Nabriva Therapeutics, PLC | 1 | $22 |
| Bristol Myers Squibb | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $16 |
| Glenmark Therapeutics Inc. | 1 | $16 |
| Viiv Healthcare Company | 1 | $15 |
| Organogenesis Inc. | 1 | $15 |
| EPI Health, LLC | 1 | $15 |
| Sandoz | 1 | $14 |
| Aclaris Therapeutics, Inc. | 1 | $13 |
How this compares
$6,920 in reported general payments places this provider in the 60th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 27 | $98,757 |
| Ketoconazole | 141 | $2,101 |
| Clobetasol Propionate | 42 | $2,051 |
| Metronidazole | 28 | $1,699 |
| Fluticasone Propionate | 83 | $1,266 |
| Doxycycline Hyclate | 61 | $1,231 |
| Fluocinonide | 31 | $1,129 |
| Fluorouracil | 15 | $1,019 |
| Ciclopirox | 23 | $652 |
| Minocycline Hcl | 14 | $625 |
| Clindamycin Phosphate | 16 | $589 |
| Mometasone Furoate | 34 | $542 |
| Triamcinolone Acetonide | 60 | $436 |
| Fluconazole | 19 | $407 |
| ValacyclovirValacyclovir Hcl | 21 | $321 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Woodstock
- David CohenMacon$5.5M
- Jamie WeismanAtlanta$4.9M
- Tiffani HamiltonAlpharetta$3.3M
- Firas HougeirDouglasville$3.3M
- Jonathan WeissSnellville$2.4M
- Mark KnautzPowder Springs$1.7M
- Gerald SlagelFayetteville$1.2M
- Zakiya RiceAtlanta$1.1M
- Corinne HowingtonSavannah$874K
- Alia BrownSnellville$838K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.